PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol

27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by st...

Full description

Saved in:
Bibliographic Details
Published inThe Korean journal of physiology & pharmacology Vol. 21; no. 3; pp. 301 - 308
Main Authors Son, Yonghae, Kim, Bo-Young, Park, Young Chul, Eo, Seong-Kug, Cho, Hyok-rae, Kim, Koanhoi
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Physiological Society and The Korean Society of Pharmacology 01.05.2017
대한약리학회
Subjects
Online AccessGet full text
ISSN1226-4512
2093-3827
DOI10.4196/kjpp.2017.21.3.301

Cover

Loading…
Abstract 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol.
AbstractList 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol. KCI Citation Count: 3
27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol.
27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol.27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the PI3K and the ERK pathways in the 27OHChol-induced differentiation. Up-regulation of mDC-specific markers like CD80, CD83 and CD88 induced by stimulation with 27OHChol was significantly reduced in the presence of LY294002, an inhibitor of PI3K, and U0126, an inhibitor of ERK. Surface expression of MHC class I and II molecules elevated by 27OHChol was decreased to basal levels in the presence of the inhibitors. Treatment with LY294002 or U0126 resulted in recovery of endocytic activity which was reduced by 27OHChol. CD197 expression and cell adherence enhanced by 27OHChol were attenuated in the presence of the inhibitors. Transcription and surface expression of CD molecules involved in atherosclerosis such as CD105, CD137 and CD166 were also significantly decreased by treatment with LY294002 and U0126. These results mean that the PI3K and the ERK signaling pathways are necessary for differentiation of monocytic cells into mDCs and involved in over-expression of atherosclerosis-associated molecules in response to 27OHChol.
Author Kim, Koanhoi
Kim, Bo-Young
Park, Young Chul
Cho, Hyok-rae
Son, Yonghae
Eo, Seong-Kug
AuthorAffiliation 1 Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea
5 Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea
4 Institute of Marine BioTechnology, Pusan National University, Busan 46241, Korea
2 Department of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea
3 College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Korea
AuthorAffiliation_xml – name: 4 Institute of Marine BioTechnology, Pusan National University, Busan 46241, Korea
– name: 2 Department of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea
– name: 5 Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea
– name: 1 Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea
– name: 3 College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Korea
Author_xml – sequence: 1
  givenname: Yonghae
  surname: Son
  fullname: Son, Yonghae
  organization: Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea., Institute of Marine BioTechnology, Pusan National University, Busan 46241, Korea
– sequence: 2
  givenname: Bo-Young
  surname: Kim
  fullname: Kim, Bo-Young
  organization: Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea
– sequence: 3
  givenname: Young Chul
  surname: Park
  fullname: Park, Young Chul
  organization: Department of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea
– sequence: 4
  givenname: Seong-Kug
  surname: Eo
  fullname: Eo, Seong-Kug
  organization: College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Iksan 54596, Korea
– sequence: 5
  givenname: Hyok-rae
  surname: Cho
  fullname: Cho, Hyok-rae
  organization: Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea
– sequence: 6
  givenname: Koanhoi
  surname: Kim
  fullname: Kim, Koanhoi
  organization: Department of Pharmacology, Pusan National University School of Medicine, Yangsan 50612, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28461772$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002217142$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kUtP3DAUha0KVAbKH-ii8rIskvqROPGmEkJARyBRIbq2HD9m3MnYqZ2ZNv8ezwxFbRddXUv-zrmPcwqOfPAGgPcYlRXm7NPq-zCUBOGmJLikJUX4DZgRxGlBW9IcgRkmhBVVjckJOE_JdQi1NapbxN-CE9JWDDcNmYH0dU7voPQaXj_eweQWXvbOL-Agx-VPOSUoo4HOb0O_NTo_oHbWmmj86OTogofBwnXwQU2jU1CZvk-Z0huV6W6CpCmWk47h16SWoTdpNDH078CxlX0y5y_1DHy7uX66-lLcP9zOry7vC1VRNhaSaq5rzE3Xtayl2GLELVdcVrwhHdNMY2pMRYxtELGIMYJIQyhliDPWUEXPwMXB10crVsqJIN2-LoJYRXH5-DQXmOZD1Dyznw_ssOnWRqu8YJS9GKJbyzjtlX__eLfMPltRV4hjzLLBxxeDGH5s8qZi7dLuHtKbsEkCt7yqCapqlNEPf_Z6bfI7lQyQA6BiSCka-4pgJHbpi136Ype-IFhQkdPPovYfkXLjPqM8r-v_J30GWfG2WQ
CitedBy_id crossref_primary_10_1016_j_jare_2019_02_005
crossref_primary_10_1097_FJC_0000000000000889
crossref_primary_10_1016_j_jsbmb_2022_106122
crossref_primary_10_3390_ijms23126361
crossref_primary_10_4196_kjpp_2024_28_2_107
crossref_primary_10_4110_in_2023_23_e40
crossref_primary_10_1016_j_intimp_2019_01_045
crossref_primary_10_1016_j_biopha_2019_109074
crossref_primary_10_4110_in_2020_20_e17
Cites_doi 10.1016/S0021-9150(98)00196-8
10.1016/j.celrep.2013.10.006
10.4062/biomolther.2014.067
10.1016/j.freeradbiomed.2014.07.026
10.3389/fimmu.2013.00139
10.1002/eji.1830270213
10.1016/j.bbrc.2013.07.046
10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C
10.1091/mbc.E11-12-0993
10.1073/pnas.97.23.12694
10.1016/j.bbrc.2013.11.052
10.1016/j.immuni.2008.08.006
10.1016/j.bbadis.2014.12.003
10.1016/j.cmet.2014.05.013
10.1038/labinvest.2010.94
10.1161/01.CIR.91.9.2488
10.1146/annurev.immunol.18.1.767
10.1128/MCB.05857-11
10.5551/jat.13.82
10.1016/j.taap.2013.12.007
10.4049/jimmunol.160.9.4587
10.1182/blood-2011-11-370130
10.1074/jbc.M113.524819
10.1161/CIRCULATIONAHA.107.699173
10.1016/j.freeradbiomed.2015.12.007
ContentType Journal Article
Copyright Copyright © Korean J Physiol Pharmacol 2017
Copyright_xml – notice: Copyright © Korean J Physiol Pharmacol 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4196/kjpp.2017.21.3.301
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2093-3827
EndPage 308
ExternalDocumentID oai_kci_go_kr_ARTI_1361759
PMC5409116
28461772
10_4196_kjpp_2017_21_3_301
Genre Journal Article
GrantInformation_xml – fundername: ;
  grantid: NRF-2013R1A1A4A01010144; NRF-2016R1C1B1013443
GroupedDBID ---
5-W
53G
5GY
8JR
8XY
9ZL
AAYXX
ABDBF
ACUHS
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
ESX
F5P
GX1
HYE
KVFHK
MK0
OK1
P2P
P5Y
P6G
RPM
TR2
TUS
.UV
NPM
7X8
5PM
ABPTK
ACYCR
ID FETCH-LOGICAL-c436t-a3d9d519ebb86831f109f9c9a4972b6d6d13ee42ef702f06620272336096673c3
ISSN 1226-4512
IngestDate Tue Nov 21 21:37:30 EST 2023
Thu Aug 21 13:58:10 EDT 2025
Thu Jul 10 22:46:06 EDT 2025
Thu Jan 02 22:25:53 EST 2025
Thu Apr 24 23:07:51 EDT 2025
Tue Jul 01 02:33:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Dendritic cells
PI3K
27-hydroxycholesterol
Differentiation
ERK
Language English
License http://creativecommons.org/licenses/by-nc/4.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c436t-a3d9d519ebb86831f109f9c9a4972b6d6d13ee42ef702f06620272336096673c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000764.2017.21.3.002
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5409116
PMID 28461772
PQID 1894520450
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1361759
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5409116
proquest_miscellaneous_1894520450
pubmed_primary_28461772
crossref_primary_10_4196_kjpp_2017_21_3_301
crossref_citationtrail_10_4196_kjpp_2017_21_3_301
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-05-01
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 2017-05-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle The Korean journal of physiology & pharmacology
PublicationTitleAlternate Korean J Physiol Pharmacol
PublicationYear 2017
Publisher The Korean Physiological Society and The Korean Society of Pharmacology
대한약리학회
Publisher_xml – name: The Korean Physiological Society and The Korean Society of Pharmacology
– name: 대한약리학회
References Wu (10.4196/kjpp.2017.21.3.301_ref8) 2013; 5
van de Laar (10.4196/kjpp.2017.21.3.301_ref16) 2012; 119
Umetani (10.4196/kjpp.2017.21.3.301_ref7) 2014; 20
Son (10.4196/kjpp.2017.21.3.301_ref5) 2013; 438
Majmundar (10.4196/kjpp.2017.21.3.301_ref18) 2012; 32
So (10.4196/kjpp.2017.21.3.301_ref24) 2013; 4
Ma (10.4196/kjpp.2017.21.3.301_ref25) 2014; 289
Lee (10.4196/kjpp.2017.21.3.301_ref23) 2012; 23
Kim (10.4196/kjpp.2017.21.3.301_ref3) 2014; 274
Luther (10.4196/kjpp.2017.21.3.301_ref20) 2000; 97
Seo (10.4196/kjpp.2017.21.3.301_ref12) 2015; 23
Banchereau (10.4196/kjpp.2017.21.3.301_ref13) 2000; 18
Willimann (10.4196/kjpp.2017.21.3.301_ref19) 1998; 28
Alvarez (10.4196/kjpp.2017.21.3.301_ref21) 2008; 29
Vurusaner (10.4196/kjpp.2017.21.3.301_ref9) 2014; 77
Bobryshev (10.4196/kjpp.2017.21.3.301_ref17) 2010; 90
Vurusaner (10.4196/kjpp.2017.21.3.301_ref10) 2016; 91
Kim (10.4196/kjpp.2017.21.3.301_ref6) 2015; 1852
Palucka (10.4196/kjpp.2017.21.3.301_ref14) 1998; 160
Chapuis (10.4196/kjpp.2017.21.3.301_ref15) 1997; 27
Kim (10.4196/kjpp.2017.21.3.301_ref4) 2013; 442
Brown (10.4196/kjpp.2017.21.3.301_ref1) 1999; 142
Berliner (10.4196/kjpp.2017.21.3.301_ref2) 1995; 91
Olofsson (10.4196/kjpp.2017.21.3.301_ref11) 2008; 117
Piao (10.4196/kjpp.2017.21.3.301_ref22) 2006; 13
24954418 - Cell Metab. 2014 Jul 1;20(1):172-82
26689473 - Free Radic Biol Med. 2016 Feb;91:93-104
24482231 - J Biol Chem. 2014 Mar 7;289(10):6921-33
7729036 - Circulation. 1995 May 1;91(9):2488-96
25593648 - Biomol Ther (Seoul). 2015 Jan;23(1):84-9
9920502 - Atherosclerosis. 1999 Jan;142(1):1-28
23876312 - Biochem Biophys Res Commun. 2013 Aug 16;438(1):161-8
24269812 - Biochem Biophys Res Commun. 2013 Dec 13;442(3-4):159-64
11070085 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12694-9
22593212 - Mol Biol Cell. 2012 Jul;23 (13):2412-23
23760533 - Front Immunol. 2013 Jun 07;4:139
9645384 - Eur J Immunol. 1998 Jun;28(6):2025-34
25497142 - Biochim Biophys Acta. 2015 Mar;1852(3):442-50
22006022 - Mol Cell Biol. 2012 Jan;32(1):36-49
24370436 - Toxicol Appl Pharmacol. 2014 Feb 1;274(3):462-70
10837075 - Annu Rev Immunol. 2000;18:767-811
25110320 - Free Radic Biol Med. 2014 Dec;77:376-85
9045914 - Eur J Immunol. 1997 Feb;27(2):431-41
9574566 - J Immunol. 1998 May 1;160(9):4587-95
18799141 - Immunity. 2008 Sep 19;29(3):325-42
22323450 - Blood. 2012 Apr 12;119(15):3383-93
24210818 - Cell Rep. 2013 Nov 14;5(3):637-45
20458277 - Lab Invest. 2010 Jul;90(7):970-84
16733295 - J Atheroscler Thromb. 2006 Apr;13(2):82-9
18285570 - Circulation. 2008 Mar 11;117(10):1292-301
References_xml – volume: 142
  start-page: 1
  year: 1999
  ident: 10.4196/kjpp.2017.21.3.301_ref1
  publication-title: Atherosclerosis
  doi: 10.1016/S0021-9150(98)00196-8
– volume: 5
  start-page: 637
  year: 2013
  ident: 10.4196/kjpp.2017.21.3.301_ref8
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2013.10.006
– volume: 23
  start-page: 84
  year: 2015
  ident: 10.4196/kjpp.2017.21.3.301_ref12
  publication-title: Biomol Ther (Seoul)
  doi: 10.4062/biomolther.2014.067
– volume: 77
  start-page: 376
  year: 2014
  ident: 10.4196/kjpp.2017.21.3.301_ref9
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2014.07.026
– volume: 4
  start-page: 139
  year: 2013
  ident: 10.4196/kjpp.2017.21.3.301_ref24
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2013.00139
– volume: 27
  start-page: 431
  year: 1997
  ident: 10.4196/kjpp.2017.21.3.301_ref15
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830270213
– volume: 438
  start-page: 161
  year: 2013
  ident: 10.4196/kjpp.2017.21.3.301_ref5
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.07.046
– volume: 28
  start-page: 2025
  year: 1998
  ident: 10.4196/kjpp.2017.21.3.301_ref19
  publication-title: Eur J Immunol
  doi: 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C
– volume: 23
  start-page: 2412
  year: 2012
  ident: 10.4196/kjpp.2017.21.3.301_ref23
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.E11-12-0993
– volume: 97
  start-page: 12694
  year: 2000
  ident: 10.4196/kjpp.2017.21.3.301_ref20
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.97.23.12694
– volume: 442
  start-page: 159
  year: 2013
  ident: 10.4196/kjpp.2017.21.3.301_ref4
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.11.052
– volume: 29
  start-page: 325
  year: 2008
  ident: 10.4196/kjpp.2017.21.3.301_ref21
  publication-title: Immunity
  doi: 10.1016/j.immuni.2008.08.006
– volume: 1852
  start-page: 442
  year: 2015
  ident: 10.4196/kjpp.2017.21.3.301_ref6
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbadis.2014.12.003
– volume: 20
  start-page: 172
  year: 2014
  ident: 10.4196/kjpp.2017.21.3.301_ref7
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2014.05.013
– volume: 90
  start-page: 970
  year: 2010
  ident: 10.4196/kjpp.2017.21.3.301_ref17
  publication-title: Lab Invest
  doi: 10.1038/labinvest.2010.94
– volume: 91
  start-page: 2488
  year: 1995
  ident: 10.4196/kjpp.2017.21.3.301_ref2
  publication-title: Circulation
  doi: 10.1161/01.CIR.91.9.2488
– volume: 18
  start-page: 767
  year: 2000
  ident: 10.4196/kjpp.2017.21.3.301_ref13
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.18.1.767
– volume: 32
  start-page: 36
  year: 2012
  ident: 10.4196/kjpp.2017.21.3.301_ref18
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.05857-11
– volume: 13
  start-page: 82
  year: 2006
  ident: 10.4196/kjpp.2017.21.3.301_ref22
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.13.82
– volume: 274
  start-page: 462
  year: 2014
  ident: 10.4196/kjpp.2017.21.3.301_ref3
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2013.12.007
– volume: 160
  start-page: 4587
  year: 1998
  ident: 10.4196/kjpp.2017.21.3.301_ref14
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.9.4587
– volume: 119
  start-page: 3383
  year: 2012
  ident: 10.4196/kjpp.2017.21.3.301_ref16
  publication-title: Blood
  doi: 10.1182/blood-2011-11-370130
– volume: 289
  start-page: 6921
  year: 2014
  ident: 10.4196/kjpp.2017.21.3.301_ref25
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M113.524819
– volume: 117
  start-page: 1292
  year: 2008
  ident: 10.4196/kjpp.2017.21.3.301_ref11
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.699173
– volume: 91
  start-page: 93
  year: 2016
  ident: 10.4196/kjpp.2017.21.3.301_ref10
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2015.12.007
– reference: 16733295 - J Atheroscler Thromb. 2006 Apr;13(2):82-9
– reference: 20458277 - Lab Invest. 2010 Jul;90(7):970-84
– reference: 25497142 - Biochim Biophys Acta. 2015 Mar;1852(3):442-50
– reference: 22323450 - Blood. 2012 Apr 12;119(15):3383-93
– reference: 10837075 - Annu Rev Immunol. 2000;18:767-811
– reference: 24269812 - Biochem Biophys Res Commun. 2013 Dec 13;442(3-4):159-64
– reference: 25593648 - Biomol Ther (Seoul). 2015 Jan;23(1):84-9
– reference: 26689473 - Free Radic Biol Med. 2016 Feb;91:93-104
– reference: 18799141 - Immunity. 2008 Sep 19;29(3):325-42
– reference: 24370436 - Toxicol Appl Pharmacol. 2014 Feb 1;274(3):462-70
– reference: 22006022 - Mol Cell Biol. 2012 Jan;32(1):36-49
– reference: 23760533 - Front Immunol. 2013 Jun 07;4:139
– reference: 23876312 - Biochem Biophys Res Commun. 2013 Aug 16;438(1):161-8
– reference: 25110320 - Free Radic Biol Med. 2014 Dec;77:376-85
– reference: 9574566 - J Immunol. 1998 May 1;160(9):4587-95
– reference: 24210818 - Cell Rep. 2013 Nov 14;5(3):637-45
– reference: 9645384 - Eur J Immunol. 1998 Jun;28(6):2025-34
– reference: 11070085 - Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12694-9
– reference: 22593212 - Mol Biol Cell. 2012 Jul;23 (13):2412-23
– reference: 24954418 - Cell Metab. 2014 Jul 1;20(1):172-82
– reference: 24482231 - J Biol Chem. 2014 Mar 7;289(10):6921-33
– reference: 9920502 - Atherosclerosis. 1999 Jan;142(1):1-28
– reference: 9045914 - Eur J Immunol. 1997 Feb;27(2):431-41
– reference: 7729036 - Circulation. 1995 May 1;91(9):2488-96
– reference: 18285570 - Circulation. 2008 Mar 11;117(10):1292-301
SSID ssib008505809
ssj0064464
Score 2.1012115
Snippet 27-Hydroxycholesterol induces differentiation of monocytic cells into mature dendritic cells, mDCs. In the current study we sought to determine roles of the...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 301
SubjectTerms Original
약리학
Title PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol
URI https://www.ncbi.nlm.nih.gov/pubmed/28461772
https://www.proquest.com/docview/1894520450
https://pubmed.ncbi.nlm.nih.gov/PMC5409116
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002217142
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX The Korean Journal of Physiology & Pharmacology, 2017, 21(3), , pp.301-308
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKcuGCgOVRXjIIcalSGjvN47isinapQCt2VyonK3GctnRJqjYFlX_FP2TGTty0FMRySSPXmTzmy_ibyXhMyKskgEGq74dOxtPU8XiWOUmSxPBeRTyUfqq8FAP6Hz76J5fe-1F_1Gr9bGQtrcqkK3_snVfyP1qFNtArzpK9hmatUGiAfdAvbEHDsP0nHZ-d8qGO_g8-DTuYiRGbyeXA6r7H62UHs7qmORigbyrVaa_Vaijl1BJFuNZCrrFqK4bwMTkrXUnDSlngTNYpprmgidQVFYqrJplFiA2LRR3Lr3itjpWYyk4Iq_mmNraN3p-bT_2fi3w8iS2yqoWd3xaONkGbj1smm1s3do4nm0zGgQ7znisQ4wxX42YAAwZFmy5Y2VxggI7Xr7KplW5jvYg7PDRlA2pDzdwGIHnD6nIjbnc08MC6gApnX-ZYmNQNuszt8m7Vebv09s6QaBMVwUVCKQJlCJQhmCu44Dhj8CYDz0SvFjLamMgQGKWuiGbIALBNXcHM3qOZt4Uy3_x-XVvc6Ea-yPa5PbvZuw06dHGH3K78GHpkQHmXtFR-jxwe5XFZfF3T1_TMouCQLBGnFHBKAafU4pTWOKWAU1rjFHboDk5pkVGLU6pxSiuc0mRN9-L0Prl8N7g4PnGqxT4c6XG_dGKeRim4EypJQj_kbub2oiySUexFAUv81E9drpTHVBb0WIbrFvRYwDj3wQf3Ay75A3KQF7l6RGikZCxVHCsG_FjKJA7TIIwS8JyBz_akbBO3fsxCVpXwcUGWK_FndbdJxx4zN3Vg_tr7JWhPzORUYPl2_B0XYrYQ4KSeCpeD29CP2uRFrVwBNh2fXpyrYrUUbhh5fVwnotcmD42y7UmBTsLRAWuTYAsGtgOecPuffDrRdePBOQNq4z--1q08Ibc2L-1TclAuVuoZ8PAyea6R_wuy8d6z
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PI3K+and+ERK+signaling+pathways+are+involved+in+differentiation+of+monocytic+cells+induced+by+27-hydroxycholesterol&rft.jtitle=The+Korean+journal+of+physiology+%26+pharmacology&rft.au=Son%2C+Yonghae&rft.au=Kim%2C+Bo-Young&rft.au=Park%2C+Young+Chul&rft.au=Eo%2C+Seong-Kug&rft.date=2017-05-01&rft.issn=1226-4512&rft.eissn=2093-3827&rft.volume=21&rft.issue=3&rft.spage=301&rft_id=info:doi/10.4196%2Fkjpp.2017.21.3.301&rft.externalDBID=n%2Fa&rft.externalDocID=10_4196_kjpp_2017_21_3_301
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1226-4512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1226-4512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1226-4512&client=summon